Neuronetics, Inc. (STIM)
USD 4.58
(2.69%)
USD 4.58
(2.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -30.18 Million USD | 23.0% |
| 2022 | -39.2 Million USD | -10.13% |
| 2021 | -35.6 Million USD | -10.3% |
| 2020 | -32.27 Million USD | 5.9% |
| 2019 | -34.3 Million USD | -42.34% |
| 2018 | -24.09 Million USD | -50.05% |
| 2017 | -16.05 Million USD | -42.95% |
| 2016 | -11.23 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -9.83 Million USD | -24.88% |
| 2024 Q1 | -7.87 Million USD | -46.42% |
| 2023 Q3 | -9.39 Million USD | -91.61% |
| 2023 FY | -30.18 Million USD | 23.0% |
| 2023 Q1 | -11.13 Million USD | -25.78% |
| 2023 Q2 | -4.9 Million USD | 55.98% |
| 2023 Q4 | -5.37 Million USD | 42.74% |
| 2022 Q3 | -7.76 Million USD | 25.5% |
| 2022 FY | -39.2 Million USD | -10.13% |
| 2022 Q1 | -11.54 Million USD | -51.16% |
| 2022 Q2 | -10.42 Million USD | 9.7% |
| 2022 Q4 | -8.85 Million USD | -14.0% |
| 2021 Q1 | -7.88 Million USD | -115.5% |
| 2021 Q4 | -7.63 Million USD | 6.33% |
| 2021 Q3 | -8.15 Million USD | -8.32% |
| 2021 Q2 | -7.52 Million USD | 4.52% |
| 2021 FY | -35.6 Million USD | -10.3% |
| 2020 Q4 | -3.65 Million USD | -6.99% |
| 2020 Q2 | -7.76 Million USD | 38.44% |
| 2020 Q3 | -3.41 Million USD | 55.98% |
| 2020 FY | -32.27 Million USD | 5.9% |
| 2020 Q1 | -12.61 Million USD | -66.97% |
| 2019 FY | -34.3 Million USD | -42.34% |
| 2019 Q4 | -7.55 Million USD | -10.0% |
| 2019 Q3 | -6.86 Million USD | 3.2% |
| 2019 Q2 | -7.09 Million USD | 5.78% |
| 2019 Q1 | -7.52 Million USD | -22.56% |
| 2018 Q4 | -6.14 Million USD | -23.83% |
| 2018 FY | -24.09 Million USD | -50.05% |
| 2018 Q3 | -4.96 Million USD | 33.82% |
| 2018 Q2 | -7.49 Million USD | -36.37% |
| 2018 Q1 | -5.49 Million USD | -11.64% |
| 2017 FY | -16.05 Million USD | -42.95% |
| 2017 Q1 | -4.51 Million USD | 0.0% |
| 2017 Q4 | -4.92 Million USD | -31.2% |
| 2017 Q3 | -3.75 Million USD | -30.86% |
| 2017 Q2 | -2.86 Million USD | 36.46% |
| 2016 FY | -11.23 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 65.881% |
| Biodesix, Inc. | -52.14 Million USD | 42.107% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -280.357% |
| Castle Biosciences, Inc. | -57.46 Million USD | 47.466% |
| DarioHealth Corp. | -59.42 Million USD | 49.2% |
| Exact Sciences Corporation | -204.14 Million USD | 85.212% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 103.572% |
| Illumina, Inc. | -1.16 Billion USD | 97.4% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -197.231% |
| iSpecimen Inc. | -11.09 Million USD | -171.986% |
| Standard BioTools Inc. | -74.65 Million USD | 59.563% |
| 23andMe Holding Co. | -666.7 Million USD | 95.472% |
| Medpace Holdings, Inc. | 282.81 Million USD | 110.675% |
| NeoGenomics, Inc. | -87.96 Million USD | 65.682% |
| Inotiv, Inc. | -105.14 Million USD | 71.287% |
| Psychemedics Corporation | -4.15 Million USD | -626.745% |
| Prenetics Global Limited | -62.72 Million USD | 51.87% |
| Precipio, Inc. | -5.85 Million USD | -415.787% |
| RadNet, Inc. | 3.04 Million USD | 1091.754% |
| Sotera Health Company | 51.37 Million USD | 158.761% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -1850.194% |
| Exagen Inc. | -23.68 Million USD | -27.439% |
| Natera, Inc. | -434.8 Million USD | 93.057% |
| Aspira Women's Health Inc. | -16.69 Million USD | -80.881% |
| Neogen Corporation | -9.42 Million USD | -220.444% |
| Myriad Genetics, Inc. | -112 Million USD | 73.046% |
| ICON Public Limited Company | 612.33 Million USD | 104.93% |
| Bionano Genomics, Inc. | -232.49 Million USD | 87.015% |
| CareDx, Inc | -190.28 Million USD | 84.135% |
| Check-Cap Ltd. | -17.56 Million USD | -71.841% |
| Twist Bioscience Corporation | -208.72 Million USD | 85.537% |
| Guardant Health, Inc. | -479.44 Million USD | 93.703% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -1048.289% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 82.012% |
| Sera Prognostics, Inc. | -36.24 Million USD | 16.702% |
| OPKO Health, Inc. | -188.86 Million USD | 84.015% |
| Personalis, Inc. | -108.29 Million USD | 72.124% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -203.497% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -1850.194% |
| MDxHealth SA | -43.1 Million USD | 29.956% |
| Prenetics Global Limited | -62.72 Million USD | 51.87% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -200.082% |
| Mainz Biomed B.V. | -26.29 Million USD | -14.806% |
| Trinity Biotech plc | -24.01 Million USD | -25.693% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -280.357% |